SG Americas Securities
NAMS icon

SG Americas Securities’s NewAmsterdam Pharma NAMS Stock Holding History

SG Americas Securities’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115K Buy
+3,384
New +$112K ﹤0.01% 3056
2025
Q2 		– Sell
-5,659
Closed -$116K – 3359
2025
Q1 		$116K Buy
+5,659
New +$126K ﹤0.01% 2932

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

SG Americas Securities's NAMS Position: Q2 2026 in Review

SG Americas Securities opened a new position in NewAmsterdam Pharma (NAMS) in Q2 2026: 3,384 shares worth $115K. The stake represents ﹤0.01% of the portfolio and ranks #3056 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in NAMS as recently as Q1 2025.

SG Americas Securities first reported a position in NAMS in Q1 2025 and has held it in 2 quarters since. The position peaked at $116K in Q1 2025. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • SG Americas Securities held 3,384 shares of NewAmsterdam Pharma worth $115K as of Q2 2026.
  • NewAmsterdam Pharma was a new SG Americas Securities position in Q2 2026.
  • NewAmsterdam Pharma made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3056 holding.
  • SG Americas Securities first reported a position in NewAmsterdam Pharma in Q1 2025 and has held it in 2 quarters since.
  • SG Americas Securities's NewAmsterdam Pharma position peaked at $116K in Q1 2025.
  • 194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.